The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling
Suji Han(Samsung (South Korea)), Do‐Hyun Nam(Samsung Medical Center)
Cited by 23
Related Papers
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
|Laboratory Investigation|2008|331
Spatiotemporal Evolution of the Primary Glioblastoma Genome
|Cancer Cell|2015|320
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
|Cell Reports|2013|239
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
|Neuro-Oncology|2018|202
Prognostic significance of c‐Met expression in glioblastomas
|Cancer|2008|182